Welcome to our dedicated page for Ensign Group SEC filings (Ticker: ENSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ensign Group, Inc. (Nasdaq: ENSG) files detailed reports with the U.S. Securities and Exchange Commission that describe its post-acute healthcare operations, skilled nursing and senior living services, and healthcare real estate activities. This SEC filings page brings together those documents, along with AI-powered tools that help explain the information they contain.
Ensign’s current reports on Form 8-K discuss topics such as quarterly financial results, the use of non-GAAP financial measures, and changes in board composition and executive roles. In these filings, the company explains how it calculates measures like Adjusted Net Income, Adjusted Earnings per Share, EBITDA, Adjusted EBITDA, Adjusted EBITDAR, Adjusted EBT and Funds from Operations (FFO) for its Standard Bearer real estate segment. These definitions help investors understand how Ensign evaluates performance in its skilled services and real estate businesses.
Through this page, users can access Ensign’s annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K as they are made available on EDGAR. AI-generated summaries highlight key points from lengthy filings, such as segment descriptions, the role of Standard Bearer Healthcare REIT, Inc., and the company’s approach to non-GAAP metrics. The platform also surfaces relevant information from Forms 3, 4 and 5 related to equity ownership and transactions by directors and officers, giving additional context on insider activity.
By combining real-time SEC updates with AI explanations, this ENSG filings page is intended to make Ensign’s regulatory disclosures more accessible to investors who want to understand its skilled nursing, senior living and healthcare real estate operations in greater depth.
Ensign Group (ENSG) reported an insider equity change as a director acquired 600 shares of common stock on October 15, 2025 at a reported price of $0. Following this transaction, the director’s direct beneficial ownership is 2,400 shares.
The filing notes these 600 shares vest in three equal annual installments beginning October 15, 2026, indicating the award will deliver shares over time rather than immediately.
Barry M. Smith, a director of Ensign Group, Inc. (ENSG), reported a sale of 700 shares of the company's common stock on 10/01/2025 at a price of $172 per share. The filing shows 25,152 shares remained beneficially owned by Mr. Smith after the transaction. The Form 4 states the sale was effected under a Rule 10b5-1 trading plan adopted on July 31, 2024. The form was signed by a power of attorney on 10/03/2025.
Form 144 filed for Ensign Group, Inc. (ENSG) reports a proposed sale of 700 common shares through Fidelity Brokerage Services with an aggregate market value of $120,400, approximately 700 of the company's 57,700,157 outstanding shares, with an approximate sale date of 10/01/2025 on NASDAQ. The filing lists prior sales by the same person on 07/01/2025, 08/01/2025, and 09/02/2025, each of 700 shares with gross proceeds shown. Acquisition details show the shares were received as restricted stock vesting on 01/15/2022 and 01/18/2023 as compensation.
Uychiat Pison Marivic filed an Initial Statement of Beneficial Ownership for The Ensign Group, Inc. (ENSG) reporting direct ownership of 12,963 common shares and multiple employee stock options and restricted stock awards. Reported derivative holdings include options exercisable from 08/26/2020 through 11/06/2025 covering 17,559 shares in aggregate under various exercise prices, and unvested RSAs totaling 2,040 shares subject to five-year vesting schedules.
Chad A. Keetch, CIO, EVP and Secretary of The Ensign Group, Inc. (ENSG), reported a gift disposition of 2,820 shares of Ensign common stock on 09/05/2025. The transaction is coded as a G (gift) at $0. After the reported transaction, Mr. Keetch beneficially owns 94,800 shares directly. No derivative transactions were reported. The Form 4 was signed on 09/09/2025.
The Ensign Group director Barry M. Smith reported insider dispositions on 09/02/2025. The filing shows a sale of 700 shares at $172.06 per share and a separate 1,200-share transaction coded G (a gift), leaving the reporting person with 25,852 shares beneficially owned after these transactions. The filing states the sale was executed under a Rule 10b5-1 trading plan adopted on July 31, 2024. The Form 4 was signed by a power of attorney on behalf of the reporting person on 09/04/2025. This document records routine insider activity rather than operational or financial results.
The filer submitted a Form 144 notice for the sale of 700 shares of Common stock via Fidelity Brokerage Services, with an aggregate market value of $120,442 and an approximate sale date of 09/02/2025 on NASDAQ. The shares were acquired through restricted stock vesting on 01/15/2022 (424 shares) and 04/18/2024 (276 shares) and were paid as compensation. The filing lists three prior sales by Barry Smith in the past three months: 700 shares on 06/02/2025 for $102,557, 700 shares on 07/01/2025 for $107,436, and 700 shares on 08/01/2025 for $105,000. The notice includes the standard signature representation that the seller is not aware of undisclosed material adverse information.
The Ensign Group, Inc. reported compensation actions related to the previously announced retirement of director Christopher Christensen from its Board effective September 1, 2025. The compensation committee approved the accelerated vesting, as of August 21, 2025, of 3,300 unvested restricted stock awards and 21,750 unvested stock options in the company, plus 1,000 unvested restricted stock awards in Standard Bearer Healthcare REIT, Inc.
Mr. Christensen will receive a cash bonus of $2,070,000 for services from January 1, 2025 to September 1, 2025, and a cash subsidy of up to $150,000 as prepayment for five years of health insurance premiums starting September 1, 2025. He may provide advisory services to management for up to one year at a rate not exceeding $100,000 per year. Under the Standard Bearer 2022 Omnibus Incentive Plan, the company will repurchase 19,726 Standard Bearer common shares and one preferred share from Mr. Christensen for a total of $287,393, based on third-party fair market value.
The Ensign Group director Daren Shaw reported a sale of 1,000 shares of ENSG common stock on 08/15/2025 at a price of $166.17 per share. After the reported sale Mr. Shaw beneficially owned 24,526 shares directly. The filing discloses the sale was effected under a Rule 10b5-1 trading plan adopted May 7, 2025, indicating the transaction followed a pre-established written plan. The Form 4 was signed by a power of attorney on 08/19/2025.
The Ensign Group, Inc. (ENSG) Form 144 notice reports a proposed sale of 1,000 common shares through Fidelity Brokerage Services with an aggregate market value of $166,170.00, scheduled approximately 08/15/2025 on NASDAQ. The shares were acquired via restricted stock vesting on various dates (2018 and 2025) and paid as compensation. The filer disclosed prior sales of 1,999 shares on 05/15/2025 generating $290,794.53. The notice includes the required attestation about material nonpublic information.
FAQ
What is the current stock price of Ensign Group (ENSG)?
What is the market cap of Ensign Group (ENSG)?
